Streptococcus Equi Antibody
Streptococcus Equi Antibody is a therapeutic approach to aid in the treatment of Strangles, a highly contagious bacterial disease of the upper respiratory tract. Administration of Streptococcus Equi Antibody works to support the equine immune system by introducing strangles-specific antibody to the horse’s system. Our controlled challenge showed that Streptococcus Equi Antibody can reduce the mortality, duration, and severity of Strangles.
Mg Biologics is the only USDA facility that manufactures a licensed product to aid in the treatment of Streptococcus equi. Streptococcus Equi Antibody can be administered intravenously at any age of life after the clinical signs of disease have been observed. Dosage recommendations are 200 ml/100 lbs body weight. Conditionally licensed; definitive potency and efficacy studies are in progress.